Document is current
Any future updates will be listed below
-
Authors
Ju, Bin
Zhang, Qi
Wang, Ziyi
Aw, Zhen Qin https://orcid.org/0000-0002-6097-4099
Chen, Peng https://orcid.org/0000-0002-9041-8392
Zhou, Bing
Wang, Ruoke https://orcid.org/0000-0002-8040-7913
Ge, Xiangyang
Lv, Qining
Cheng, Lin
Zhang, Rui https://orcid.org/0000-0003-0024-389X
Wong, Yi Hao
Chen, Huixin
Wang, Haiyan
Shan, Sisi https://orcid.org/0000-0002-7184-6818
Liao, Xuejiao
Shi, Xuanling
Liu, Lei
Chu, Justin Jang Hann https://orcid.org/0000-0002-1673-6819
Wang, Xinquan https://orcid.org/0000-0003-3136-8070
Zhang, Zheng https://orcid.org/0000-0002-3544-1389
Zhang, Linqi https://orcid.org/0000-0003-4931-509X
-
Funding
Funding for this research was provided by:
the National Key Plan for Scientific Research and Development of China
the National Natural Science Foundation
the National Natural Science Foundation
the National Key Plan for Scientific Research and Development of China
Singapore National Medical Research Council Centre Grant Program
the National Natural Science Foundation
the National Science Fund for Distinguished Young Scholars
- License Information
-
More Information
Article History
Received: 23 May 2022
Accepted: 3 February 2023
First Online: 13 March 2023
Competing interests
: Patent applications have been filed that cover some of the antibodies presented here (patent application nos. 202310046052.1, 202310046053.6, 202310046054.0, 202310046051.7, 202310046056.X, 202310107070.6, 202310130257.8, 202310050519.X, 202310118826.7, 202310050250.5, 202310050475.0 and 202310050170.X). L.Z., Z.Z., Q.Z., B.J., P.C., B.Z. and X.S. are the inventors. The other authors declare no competing interests.
